NIVFW
NewGenIvf Group Limited WarrantsNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.03
52W High
$0.04
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
209.00%
Forward P/E
—
PEG Ratio
—
About NewGenIvf Group Limited Warrants
NewGenIvf Group Limited Warrants (NIVFW) is a forward-thinking biotechnology company specializing in assisted reproductive technology (ART) to transform the landscape of reproductive healthcare. Focused on enhancing fertility success rates and care quality, the firm employs innovative research and advanced technologies to meet the burgeoning demand for IVF services worldwide. With a strategic emphasis on addressing unmet needs in the fertility sector, NewGenIvf is poised for growth through future partnerships and continuous service enhancements aimed at improving patient outcomes in an increasingly competitive market.
Fundamentals
| Revenue (TTM) | $4.73M |
| Gross Profit (TTM) | 955,850 |
| EBITDA | $-10.54M |
| Operating Margin | -349.10% |
| Return on Equity | 79.40% |
| Return on Assets | -36.90% |
| Revenue/Share (TTM) | $102.73 |
| Book Value | $110.50 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.90% |
| Shares Outstanding | 0 |
| Float | 568,470 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/25/2026